Abstract
A new antibiotic cefminox (CMNX, MT-141) was administered to 54 patients with severe infections accompanying various hematological diseases. The rate of effectiveness was 55.3% on the whole. Mild liver dysfunction was observed in 3 cases, which recovered quickly following the stop of the administration.
MeSH terms
-
Adult
-
Aged
-
Bacterial Infections / complications
-
Bacterial Infections / drug therapy*
-
Cephamycins / therapeutic use*
-
Female
-
Humans
-
Leukemia / complications*
-
Lymphoma / complications*
-
Male
-
Middle Aged
-
Pneumonia / complications
-
Pneumonia / drug therapy
-
Sepsis / complications
-
Sepsis / drug therapy